Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-03 Sale |
2020-12-04 7:18 pm |
Seagen Inc. | SGEN | SIEGALL CLAY B President and CEO |
21,253 | $179.28 | $3,810,144 | 2,388,746 (Direct) |
View |
| 2020-08-31 Sale |
2020-09-02 7:24 pm |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
14,351 | $155.69 | $2,234,367 | 715,209 (Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 6:26 pm |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
27,060 | $158.17 | $4,280,053 | 719,261 (Direct) |
View |
| 2020-08-10 Sale |
2020-08-13 06:04 am |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $156.74 | $4,463,263 | 776,595 (Direct) |
View |
| 2020-08-07 Sale |
2020-08-11 12:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
34,750 | $85.37 | $2,966,736 | 4,146 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-03 Exercise |
2020-12-04 7:18 pm |
N/A 2021-08-24 |
Seagen Inc. | SGEN | SIEGALL CLAY B President and CEO |
21,253 | $0 | 2,388,746 (Direct) |
View |
| 2020-12-03 Exercise |
2020-12-04 7:18 pm |
N/A N/A |
Seagen Inc. | SGEN | SIEGALL CLAY B President and CEO |
21,253 | $15.46 | 2,388,746 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 6:35 pm |
N/A 2021-08-24 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
10,299 | $0 | 729,560 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 6:35 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
3,831 | $26.1 | 729,560 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 6:35 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
6,468 | $15.46 | 729,560 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:34 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
97,365 | $0 | 815,704 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-13 06:04 am |
N/A 2020-08-27 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $0 | 776,595 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-13 06:04 am |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $12 | 776,595 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 12:21 pm |
N/A 2024-07-09 |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
25,000 | $0 | 4,146 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 12:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
7,500 | $40.37 | 4,146 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 12:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
17,500 | $21 | 4,146 (Direct) |
View |